UK Healthtech SMEs Voice The Challenges They Face In The Market
Multi-part program to help companies navigate the regulatory maze
A multi-stakeholder research and funding program led by deeptech innovation organization CPI has produced two UK medtech industry outlook reports and overseen a £7m innovation funding scheme. Training to help SMEs navigate their way through the medtech regulatory maze is another part the program, the findings of which were released to the public this month.
You may also be interested in...
While the UK continues to develop the future medtech regulatory system for Great Britain, a new market access report recommends how the MHRA should simplify regulatory processes for SMEs.
The COVID-19 pandemic put disease diagnosis in the spotlight for the public and national health care systems alike. A UK report highlights how the IVD industry must capitalize on this unique moment in time.
The UK regulator is likely to establish mid-2024 as the new deadline for the standstill period during which CE-marked devices may access the UK market. Compulsory UKCA marking would accordingly also be delayed by a year.